FR1500996A - Préparation de capsules médicinales à partir d'éthers d'hydroxyalkylcellulose, en utilisant un solvant aqueux ou non - Google Patents

Préparation de capsules médicinales à partir d'éthers d'hydroxyalkylcellulose, en utilisant un solvant aqueux ou non

Info

Publication number
FR1500996A
FR1500996A FR75433A FR75433A FR1500996A FR 1500996 A FR1500996 A FR 1500996A FR 75433 A FR75433 A FR 75433A FR 75433 A FR75433 A FR 75433A FR 1500996 A FR1500996 A FR 1500996A
Authority
FR
France
Prior art keywords
preparation
aqueous solvent
medicinal capsules
hydroxyalkylcellulose ethers
hydroxyalkylcellulose
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR75433A
Other languages
English (en)
French (fr)
Inventor
George King Greminger Jr
Lewis Eugene Davis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dow Chemical Co
Original Assignee
Dow Chemical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dow Chemical Co filed Critical Dow Chemical Co
Application granted granted Critical
Publication of FR1500996A publication Critical patent/FR1500996A/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L1/00—Compositions of cellulose, modified cellulose or cellulose derivatives
    • C08L1/08—Cellulose derivatives
    • C08L1/26—Cellulose ethers
    • C08L1/28—Alkyl ethers
    • C08L1/284—Alkyl ethers with hydroxylated hydrocarbon radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A61J3/07—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of capsules or similar small containers for oral use
    • A61J3/071—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of capsules or similar small containers for oral use into the form of telescopically engaged two-piece capsules
    • A61J3/077—Manufacturing capsule shells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B11/00—Preparation of cellulose ethers
    • C08B11/02—Alkyl or cycloalkyl ethers
    • C08B11/04—Alkyl or cycloalkyl ethers with substituted hydrocarbon radicals
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B11/00—Preparation of cellulose ethers
    • C08B11/193—Mixed ethers, i.e. ethers with two or more different etherifying groups
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09D—COATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
    • C09D101/00—Coating compositions based on cellulose, modified cellulose, or cellulose derivatives
    • C09D101/08—Cellulose derivatives
    • C09D101/26—Cellulose ethers
    • C09D101/28—Alkyl ethers
    • C09D101/284—Alkyl ethers with hydroxylated hydrocarbon radicals
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S206/00—Special receptacle or package
    • Y10S206/828—Medicinal content

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Materials Engineering (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Wood Science & Technology (AREA)
  • Epidemiology (AREA)
  • Manufacturing & Machinery (AREA)
  • Medicinal Preparation (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Furnace Details (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
FR75433A 1965-09-07 1966-09-06 Préparation de capsules médicinales à partir d'éthers d'hydroxyalkylcellulose, en utilisant un solvant aqueux ou non Expired FR1500996A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US48561665A 1965-09-07 1965-09-07
US48561565A 1965-09-07 1965-09-07

Publications (1)

Publication Number Publication Date
FR1500996A true FR1500996A (fr) 1967-11-10

Family

ID=27048417

Family Applications (1)

Application Number Title Priority Date Filing Date
FR75433A Expired FR1500996A (fr) 1965-09-07 1966-09-06 Préparation de capsules médicinales à partir d'éthers d'hydroxyalkylcellulose, en utilisant un solvant aqueux ou non

Country Status (8)

Country Link
US (1) US3493407A (enExample)
BE (1) BE686537A (enExample)
DE (1) DE1617432C2 (enExample)
FR (1) FR1500996A (enExample)
GB (1) GB1144225A (enExample)
NL (1) NL6612510A (enExample)
NO (1) NO122091B (enExample)
SE (1) SE337654B (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2073288A2 (enExample) * 1969-12-26 1971-10-01 Midy Claude Ctre Rech
CN113244187A (zh) * 2021-05-13 2021-08-13 青岛益青生物科技股份有限公司 一种新配方肠溶羟丙甲纤维素空心胶囊及其制备方法

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3617588A (en) * 1969-06-16 1971-11-02 Dow Chemical Co Dip-coating process for preparing cellulose ether capsule shells
US3839319A (en) * 1973-01-26 1974-10-01 Dow Chemical Co Hydroxypropyl methylcellulose ethers and method of preparation
SE403782B (sv) * 1973-03-14 1978-09-04 Mo Och Domsjoe Ab Nonjoniska cellulosaetrar
US3873518A (en) * 1973-12-14 1975-03-25 Dow Chemical Co Water soluble ternary cellulose ethers
CA1045976A (en) * 1974-05-02 1979-01-09 William J. Asher Liquid membrane encapsulated medicinals and uses thereof
US4001211A (en) * 1974-12-02 1977-01-04 The Dow Chemical Company Pharmaceutical capsules from improved thermogelling methyl cellulose ethers
US4026986A (en) * 1975-05-22 1977-05-31 The Dow Chemical Company Capsule shell
DE2554558C3 (de) * 1975-12-04 1981-11-05 Hoechst Ag, 6000 Frankfurt Verfahren zum Beschichten eines Bandes aus hydrophilem Material mit Puder aus einem modifizierten Celluloseether
GB1593261A (en) * 1976-07-23 1981-07-15 Inveresk Res Int Controlled release suppository
JPS54105223A (en) * 1977-12-29 1979-08-18 Yamanouchi Pharmaceut Co Ltd Coating agent for solid medicine
US4365060A (en) * 1979-04-28 1982-12-21 Shin-Etsu Chemical Co. Ltd. Enterosoluble capsules
US4790881A (en) * 1982-03-26 1988-12-13 Warner-Lambert Company Molded hydrophilic polymer
US4614545A (en) * 1985-08-15 1986-09-30 The Dow Chemical Company Hydroxypropyl methyl cellulose thickening agents for organic liquids
PT82093B (pt) 1985-02-28 1988-07-01 Dow Chemical Co Processo para a preparacao de eteres de hidroxipropil metil celulose uteis como agentes de suspensao para polimerizacao por suspensao do cloreto de vinilo e como agentes de espassamento para liquidos organicos
KR900000254B1 (ko) * 1986-05-12 1990-01-24 신에쯔까 가가꾸 고우교우 가부시끼가이샤 의약용 경질 캅셀의 제조방법과 그 제조장치
US5698155A (en) * 1991-05-31 1997-12-16 Gs Technologies, Inc. Method for the manufacture of pharmaceutical cellulose capsules
FR2757173A1 (fr) * 1996-12-17 1998-06-19 Warner Lambert Co Compositions polymeres d'origine non-animale pour la formation de films
GB2366780A (en) * 2000-07-07 2002-03-20 Bioprogress Tech Int Inc Foam capsules
US6776831B2 (en) * 2000-07-20 2004-08-17 Dupont Canada Inc. High temperature and high humidity release coating for polymer film
GB0210859D0 (en) * 2002-05-13 2002-06-19 Bioprogress Technology Ltd Modified polymeric films
GB0314832D0 (en) * 2003-06-25 2003-07-30 Phoqus Pharmaceuticals Ltd Production of capsule shells and capsules
EP1752140A1 (en) * 2005-08-12 2007-02-14 Warner-Lambert Company LLC Method for banding hard capsules using hydroxypropylmethyl cellulose (HPMC) as a base
CA2667167C (en) 2006-10-27 2014-02-18 Pfizer Products Inc. Hydroxypropyl methyl cellulose hard capsules and process of manufacture
CA2772144A1 (en) * 2009-09-04 2011-03-10 Dominique Nicolas Cade Scented capsules
BR112012006651B1 (pt) 2009-09-24 2021-11-03 Capsugel Belgium Nv Cápsula farmacêutica dura resistente a ácido e composição aquosa compreendendo goma de gelano e hpmc
EP2627676B1 (en) 2010-10-12 2017-03-08 Dow Global Technologies LLC Novel cellulose ethers and their use
US9198868B2 (en) 2010-10-26 2015-12-01 Capsugel Belgium Nv Bulk enteric capsule shells
JP6185559B2 (ja) * 2012-04-11 2017-08-23 ダウ グローバル テクノロジーズ エルエルシー 有機希釈剤およびセルロースエーテルを含む組成物
JP6397813B2 (ja) 2012-05-02 2018-09-26 キャプシュゲル・ベルジウム・エヌ・ヴィ ヒドロキシプロピルメチルセルロースアセテートスクシネート（ｈｐｍｃａｓ）の水性分散液
WO2014017756A1 (ko) * 2012-07-23 2014-01-30 삼성정밀화학(주) 경질 캡슐 제조용 수성 조성물, 그의 제조방법, 경질 캡슐 및 경질 캡슐 스크랩의 재활용 방법
KR20140072715A (ko) * 2012-12-05 2014-06-13 삼성정밀화학 주식회사 경질 캡슐
KR102085330B1 (ko) * 2012-12-05 2020-03-05 롯데정밀화학 주식회사 두께 균일성이 개선된 경질 캡슐
KR20140072716A (ko) * 2012-12-05 2014-06-13 삼성정밀화학 주식회사 헤이즈가 개선된 필름
US20160015647A1 (en) 2013-03-07 2016-01-21 Capsugel Belgium Nv Bismuth liquid filled hard capsules
US10610491B2 (en) 2013-09-25 2020-04-07 Dow Global Technologies Llc Composition comprising an organic liquid diluent and a specific hydroxyalkyl methylcellulose
EP3065720A1 (en) 2013-11-04 2016-09-14 Capsugel Belgium NV Methods and systems for improved bioavailability of active pharmaceutical ingredients including esomeprazole
EP3077098B1 (en) * 2013-12-04 2018-03-07 Dow Global Technologies LLC Process for preparing a mixture of a cellulose derivative and a liquid diluent
KR102199595B1 (ko) * 2013-12-31 2021-01-07 롯데정밀화학 주식회사 경질 캡슐용 수성 조성물 및 이를 사용하여 제조된 경질 캡슐
KR102161001B1 (ko) * 2013-12-31 2020-09-29 롯데정밀화학 주식회사 경질 캡슐용 수성 조성물 및 이를 사용하여 제조된 경질 캡슐
KR102199596B1 (ko) * 2013-12-31 2021-01-07 롯데정밀화학 주식회사 경질 캡슐용 수성 조성물 및 이를 사용하여 제조된 경질 캡슐
US10471152B2 (en) 2014-08-29 2019-11-12 Capsugel Belgium Nv Colloidal dispersion comprising HPMCAS
JP6412853B2 (ja) 2015-12-16 2018-10-24 信越化学工業株式会社 フィルム成型用組成物
WO2019178698A1 (en) 2018-03-21 2019-09-26 Ryan Selby Vaporizer capsules and methods of manufacture
WO2021119271A1 (en) 2019-12-10 2021-06-17 Capsugel Belgium Nv Particles containing a lipid matrix core and active ingredient
BR112022014911A2 (pt) 2020-01-29 2022-09-20 Lonza Consumer Health Inc Composição de saúde articular e uso da mesma em mamíferos saudáveis
US20250170042A1 (en) 2022-03-07 2025-05-29 Lonza Greenwood Llc Method and Composition for Improving Skin Health
KR20230173034A (ko) 2022-06-16 2023-12-26 신에쓰 가가꾸 고교 가부시끼가이샤 액체 조성물
EP4561607A1 (en) 2022-07-29 2025-06-04 Lonza Greenwood LLC Method and composition for treating conditions associated with a leaky gut barrier

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB643853A (en) * 1946-04-13 1950-09-27 Lilly Co Eli Medicinal capsules and process of manufacture

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2073288A2 (enExample) * 1969-12-26 1971-10-01 Midy Claude Ctre Rech
CN113244187A (zh) * 2021-05-13 2021-08-13 青岛益青生物科技股份有限公司 一种新配方肠溶羟丙甲纤维素空心胶囊及其制备方法

Also Published As

Publication number Publication date
US3493407A (en) 1970-02-03
SE337654B (enExample) 1971-08-16
DE1617432B1 (de) 1972-05-31
NL6612510A (enExample) 1967-03-08
NO122091B (enExample) 1971-05-18
BE686537A (enExample) 1967-03-07
DE1617432C2 (de) 1978-09-28
GB1144225A (en) 1969-03-05

Similar Documents

Publication Publication Date Title
NO146456C (no) Fremgangsmaate for fremstilling av kapsellegeme, saerlig for medisindoseringskapsel
NL7507268A (nl) Werkwijze ter bereiding van 1(alpha),24-dihydroxy-chole- calciferolen, alsmede derivaten en voorlopers daar- van , alsmede farmaceutische preparaten die deze ver- bindingen als actieve componenten bevatten.
CH538281A (fr) Capsule pharmaceutique verrouillée
NL140526B (nl) Werkwijze voor de bereiding van farmacologisch werkzame dibenzothiazepinen, werkwijze voor de bereiding van farmaceutische preparaten en gevormde farmaceutische preparaten.
OA03371A (fr) Procédé de préparation de médicaments antériques.
DK119079B (da) Fremgangsmåde til fremstilling af i vnd dispergerbare veterinærmedicinske lægemiddelpræparater.
NL188948C (nl) Werkwijze ter bereiding van pyrido(1,2a)pyrimidines met werking tegen ontstekingen en tegen bloedstolling en werkwijze voor de bereiding van farmaceuttische preparaten die deze bevatten.
CH486427A (fr) Procédé de préparation d'amidines aromatiques N. substituées
NL150455B (nl) Werkwijze ter bereiding van neurotroop en psychotroop werkzame 10-(4-methylpiperazino) 10,11-dihydrodibenzo (b,f) thiepinederivaten, alsmede gevormde farmaceutische preparaten.
CH487921A (fr) Procédé de préparation de nouvelles substances physiologiquement actives
CH438251A (fr) Procédé de préparation simultanée d'époxydes et d'alcools aralcoyliques
OA03879A (fr) Procédé de préparation de 2-alcoxy-4,5-azimido benzamides.
NL172446B (nl) Werkwijze voor de bereiding van 4-aryl-1-(4.4-diarylbutyl)4-hydroxypiperidinen en werkwijze voor de bereiding van farmaceutische preparaten.
NL153084B (nl) Werkwijze ter bereiding van farmaceutische preparaten voor de orale behandeling van seborrhoea, alsmede de verkregen preparaten.
BE787126A (fr) Pyrimidines substituees, procedes de preparation de ces composes et medicaments contenant lesdits composes
SE383521B (sv) Forfarande for framstellning av kardenolid-3-(2',3-dedesoxi-2,'3'-oxido-glykosider).
OA01792A (fr) Nouveaux composés alicycliques dérivés de la podophyllotoxine et leur préparation.
DK113596B (da) Fremgangsmåde ved fremstilling af faste pharmaceutiske præparater.
NL142592B (nl) Werkwijze voor het bereiden van amidinen of daarvan afgeleide zuur-additiezouten, die werkzaam zijn als antagonisten van 5-hydroxytryptamine, en van farmaceutische preparaten, die ten minste een van deze verbindingen als werkzame verbinding bevatten.
OA02648A (fr) Glucosides dérivant de composés apparentés à la podophyllotoxine et leur préparation.
OA01758A (fr) Procédé pour la préparation de compositions pharmaceutiques.
OA01492A (fr) Préparation de monothiocarbonates d'alcoylènes.
AU412163B2 (en) Preparation of medicinal capsules from hydroxyalkylcellulose ethers using an aqueous or non-aqueous solvent
FR1462247A (fr) Procédé de préparation d'époxydes d'alcanes-1, 2
BE619513A (fr) Dérivés le tétrahydroisoquinoléine, leur préparation et compositions pharmaceutiques en contenant